Stada released 9m figures. They show revenues of €1,533.5m (+3%), EBITDA of €281.2m (-4%), and a net income of €89.9m (-9%). Free-cash flow amounted to €10.6m and net debt at the end of Q3 15 reached €1.3bn. The group confirmed its outlook for FY15 ("a substantial decrease in adjusted EBITDA and net income and a net debt/EBITDA ratio of c.3x excluding acquisitions").
12 Nov 2015
Q3 15: slowly back to normality


Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q3 15: slowly back to normality
STADA Arzneimittel AG (0OM4:LON) | 0 0 (-0.1%) | Mkt Cap: 5,400m
- Published:
12 Nov 2015 -
Author:
Fabrice Farigoule -
Pages:
2 -
Stada released 9m figures. They show revenues of €1,533.5m (+3%), EBITDA of €281.2m (-4%), and a net income of €89.9m (-9%). Free-cash flow amounted to €10.6m and net debt at the end of Q3 15 reached €1.3bn. The group confirmed its outlook for FY15 ("a substantial decrease in adjusted EBITDA and net income and a net debt/EBITDA ratio of c.3x excluding acquisitions").